두경부암에서 인유두종바이러스의 의미: 몇 가지 질문들

키워드

참고문헌 (59)

1. Parkin DM, "The global health burden of infection-associated cancers in the year 2002", Int J Cancer, 118(12), pp.3030~3044 (2006)
2. Gillison ML, "Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity", Semin Oncol, 31(6), pp.744~754 (2004)
3. Park WS, "Human papillomavirus in oropharyngeal squamous cell carcinomas in Korea:use of G1 cycle markers as new prognosticators", Head Neck, 34(10), pp.1408~1417 (2012)
4. Gillison ML, "Evidence for a causal association between human papillomavirus and a subset of head and neck cancers", J Natl Cancer Inst, 92(9), pp.709~720 (2000)
5. D’Souza G, "Case-control study of human papillomavirus and oropharyngeal cancer", N Engl J Med, 356(19), pp.1944~1956 (2007)
6. Junor EJ, "Oropharyngeal cancer. Fastest increasing cancer in Scotland, especially in men", BMJ, 340, pp.c2512~ (2010)
7. Näsman A, "Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma?", Int J Cancer, 125(2), pp.362~366 (2009)
8. Shaw R, "The increasing clinical relevance of human papillomavirus type 16 (HPV-16) infection in oropharyngeal cancer", Br J Oral Maxillofac Surg, 49(6), pp.423~429 (2011)
9. Kreimer AR, "Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review", Cancer Epidemiol Biomarkers Prev, 14(2), pp.467~475 (2005)
10. Kreimer AR, "HPV16 semiquantitative viral load and serologic biomarkers in oral and oropharyngeal squamous cell carcinomas", Int J Cancer, 115(2), pp.329~332 (2005)
11. Braakhuis BJ, "Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus", J Natl Cancer Inst, 96(13), pp.998~1006 (2004)
12. Herrero R, "Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study", J Natl Cancer Inst, 95(23), pp.1772~1783 (2003)
13. Pintos J, "Human papillomavirus infection and oral cancer: a case-control study in Montreal, Canada", Oral Oncol, 44(3), pp.242~250 (2008)
14. Schwartz SM, "Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection", J Natl Cancer Inst, 90(21), pp.1626~1636 (1998)
15. Ribeiro KB, "Low human papillomavirus prevalence in head and neck cancer:results from two large case-control studies in high-incidence regions", Int J Epidemiol, 40(2), pp.489~502 (2011)
16. Smith EM, "Human papillomavirus seropositivity and risks of head and neck cancer", Int J Cancer, 120(4), pp.825~832 (2007)
17. Gillison ML, "Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis", Vaccine, 30(Suppl 5), pp.34~54 (2012)
18. Heck JE, "Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium", Int J Epidemiol, 39(1), pp.166~181 (2010)
19. Mork J, "Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck", N Engl J Med, 344(15), pp.1125~1131 (2001)
20. Ramqvist T, "An epidemic of oropharyngeal squamous cell carcinoma (OSCC) due to human papillomavirus (HPV)infection and aspects of treatment and prevention", Anticancer Res, 31(5), pp.1515~1519 (2011)
21. Fakhry C, "Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial", J Natl Cancer Inst, 100(4), pp.261~269 (2008)
22. Chaturvedi AK, "Human papillomavirus and rising oropharyngeal cancer incidence in the United States", J Clin Oncol, 29(32), pp.4294~4301 (2011)
23. Auluck A, "Trends in oropharyngeal and oral cavity cancer incidence of human papillomavirus (HPV)-related and HPV-unrelated sites in a multicultural population: the British Columbia experience", Cancer, 116(11), pp.2635~2644 (2010)
24. Hocking JS, "Head and neck cancer in Australia between 1982 and 2005 show increasing incidence of potentially HPV-associated oropharyngeal cancers", Br J Cancer, 104(5), pp.886~891 (2011)
25. Syrjänen S, "HPV infections and tonsillar carcinoma", J Clin Pathol, 27(5), pp.449~455 (2004)
26. Blomberg M, "Trends in head and neck cancer incidence in Denmark, 1978-2007: focus on human papillomavirus associated sites", Int J Cancer, 129(3), pp.733~741 (2011)
27. Mork J, "Time trends in pharyngeal cancer incidence in Norway 1981-2005: a subsite analysis based on a reabstraction and recoding of registered cases", Cancer Causes Control, 21(9), pp.1397~1405 (2010)
28. Hammarstedt L, "Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer", Int J Cancer, 119(11), pp.2620~2623 (2006)
29. Marur S, "HPV-associated head and neck cancer: a virus-related cancer epidemic", Lancet Oncol, 11(8), pp.781~789 (2010)
30. D’Souza G, "The role of HPV in head and neck cancer and review of the HPV vaccine", Prev Med, 56(Suppl 1), pp.S5~S11 (2011)
31. Gillison ML, "Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers", J Natl Cancer Inst, 100(6), pp.407~420 (2008)
32. Smith EM, "Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers", Int J Cancer, 108(5), pp.766~772 (2004)
33. Applebaum KM, "Lack of association of alcohol and tobacco with HPV16-associated head and neck cancer", J Natl Cancer Inst, 99(23), pp.1801~1810 (2007)
34. Kreimer AR, "Oral human papillomavirus in healthy individuals: a systematic review of the literature", Sex Transm Dis, 37(6), pp.386~391 (2010)
35. Gillison ML, "Prevalence of oral HPV infection in the United States, 2009-2010", JAMA, 307(7), pp.693~703 (2012)
36. Beachler DC, "Risk factors for oral HPV infection among a high prevalence population of HIV-positive and at-risk HIV-negative adults", Cancer Epidemiol Biomarkers Prev, 21(1), pp.122~133 (2012)
37. D’Souza G, "Oral sexual behaviors associated with prevalent oral human papillomavirus infection", J Infect Dis, 199(9), pp.1263~1269 (2009)
38. D’Souza G, "Six-month natural history of oral versus cervical human papillomavirus infection", Int J Cancer, 121(1), pp.143~150 (2007)
39. Ragin CC, "Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis", Int J Cancer, 121(8), pp.1813~1820 (2007)
40. Ang KK, "Human papillomavirus and survival of patients with oropharyngeal cancer", N Engl J Med, 363(1), pp.24~35 (2010)
41. Rischin D, "Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial", J Clin Oncol, 28(27), pp.4142~4148 (2010)
42. Chaturvedi AK, "Epidemiology and clinical aspects of HPV in head and neck cancers", Head Neck Pathol, 6(Suppl 1), pp.S16~S24 (2012)
43. Hafkamp HC, "Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas", Int J Cancer, 122(12), pp.2656~2664 (2008)
44. Licitra L, "High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma", J Clin Oncol, 24(36), pp.5630~5636 (2006)
45. Dai M, "Human papillomavirus type 16 and TP53 mutation in oral cancer: matched analysis of the IARC multicenter study", Cancer Res, 64(2), pp.468~471 (2004)
46. Hoffmann TK, "T cells specific for HPV16 E7 epitopes in patients with squamous cell carcinoma of the oropharynx", Int J Cancer, 118(8), pp.1984~1991 (2006)
47. Ang KK, "Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma", Semin Radiat Oncol, 22(2), pp.128~142 (2012)
48. Grant DG, "Carcinoma of the tongue base treated by transoral laser microsurgery, part two: persistent, recurrent and second primary tumors", Laryngoscope, 116(12), pp.2156~2161 (2006)
49. Haughey BH, "Transoral laser microsurgery as primary treatment for advanced-stage oropharyngeal cancer: a United States multicenter study", Head Neck, 33(12), pp.1683~1694 (2011)
50. Weinstein GS, "Transoral robotic surgery: radical tonsillectomy", Arch Otolaryngol Head Neck Surg, 133(12), pp.1220~1226 (2007)
51. Moore EJ, "Transoral robotic surgery for oropharyngeal squamous cell carcinoma: a prospective study of feasibility and functional outcomes", Laryngoscope, 119(11), pp.2156~2164 (2009)
52. Fakhry C, "Associations between oral HPV16 infection and cytopathology: evaluation of an oropharyngeal “pap-test equivalent” in high-risk populations", Cancer Prev Res (Phila), 4(9), pp.1378~1384 (2011)
53. Gillison ML, "HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women", Cancer, 113(10 Suppl), pp.3036~3046 (2008)
54. Palefsky JM, "HPV vaccine against anal HPV infection and anal intraepithelial neoplasia", N Engl J Med, 365(17), pp.1576~1585 (2011)
55. Fakhry C, "Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial", J Natl Cancer Inst, 100(4), pp.261~269 (2008)
56. Rischin D, "Oropharyngeal cancer, human papilloma virus, and clinical trials", J Clin Oncol, 28(1), pp.1~3 (2010)
57. Ang KK, "uman papillomavirus and survival of patients with oropharyngeal cancer", N Engl J Me, 363(1), pp.24~35 (2010)
58. Sher DJ, "Relationship between radiation treatment time and overall survival after induction chemotherapy for locally advanced head-and-neck carcinoma: a subset analysis of TAX 324", Int J Radiat Oncol Biol Phys, 81(5), pp.e813~e818 (2011)
59. Lassen P, "The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer:evaluation of the randomised DAHANCA 6&7 trial", Radiother Oncol, 100(1), pp.49~55 (2011)

관련 논문AI추천